AU1134000A - Prevention of muscle mass loss with leptin receptor ligands - Google Patents
Prevention of muscle mass loss with leptin receptor ligandsInfo
- Publication number
- AU1134000A AU1134000A AU11340/00A AU1134000A AU1134000A AU 1134000 A AU1134000 A AU 1134000A AU 11340/00 A AU11340/00 A AU 11340/00A AU 1134000 A AU1134000 A AU 1134000A AU 1134000 A AU1134000 A AU 1134000A
- Authority
- AU
- Australia
- Prior art keywords
- prevention
- muscle mass
- mass loss
- receptor ligands
- leptin receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000005861 leptin receptors Human genes 0.000 title 1
- 108010019813 leptin receptors Proteins 0.000 title 1
- 239000003446 ligand Substances 0.000 title 1
- 210000003205 muscle Anatomy 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2264—Obesity-gene products, e.g. leptin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Obesity (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17946198A | 1998-10-27 | 1998-10-27 | |
| US09179461 | 1998-10-27 | ||
| PCT/US1999/025120 WO2000024418A1 (en) | 1998-10-27 | 1999-10-27 | Prevention of muscle mass loss with leptin receptor ligands |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU1134000A true AU1134000A (en) | 2000-05-15 |
Family
ID=22656692
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU11340/00A Abandoned AU1134000A (en) | 1998-10-27 | 1999-10-27 | Prevention of muscle mass loss with leptin receptor ligands |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP1128840A1 (en) |
| AU (1) | AU1134000A (en) |
| WO (1) | WO2000024418A1 (en) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996023517A1 (en) * | 1995-01-31 | 1996-08-08 | Eli Lilly And Company | Anti-obesity proteins |
| ATE259243T1 (en) * | 1995-11-22 | 2004-02-15 | Amgen Inc | OBESITY PROTEIN (OB) TO INCREASE LEAN BODY MASS |
| AU7132798A (en) * | 1997-04-17 | 1998-11-11 | Amgen, Inc. | Compositions comprising conjugates of stable, active, human ob protein with antibody fc chain and methods |
-
1999
- 1999-10-27 AU AU11340/00A patent/AU1134000A/en not_active Abandoned
- 1999-10-27 WO PCT/US1999/025120 patent/WO2000024418A1/en not_active Application Discontinuation
- 1999-10-27 EP EP99955171A patent/EP1128840A1/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000024418A1 (en) | 2000-05-04 |
| EP1128840A1 (en) | 2001-09-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU6325599A (en) | New compounds, their preparation and use | |
| AU6190199A (en) | New compounds, their preparation and use | |
| AU6325799A (en) | New compounds, their preparation and use | |
| AU6325899A (en) | New compounds, their preparation and use | |
| AU6190299A (en) | New compounds, their preparation and use | |
| AU6325699A (en) | New compounds, their preparation and use | |
| EP0928996A3 (en) | Toner preparation processes | |
| EP0928991A3 (en) | Toner preparation processes | |
| EP0928992A3 (en) | Toner preparation processes | |
| AU1704697A (en) | Leptin receptor variants | |
| TW362474U (en) | Compound torque hinge | |
| AU1698897A (en) | Leptin receptor variants | |
| AU1926000A (en) | Pth1r and pth3r receptors | |
| EP0928994A3 (en) | Toner preparation processes | |
| AU1020300A (en) | Improved cement composition | |
| AU1809600A (en) | Anti-snoring composition | |
| AU3595099A (en) | New compounds, their preparation and use | |
| AU9314298A (en) | Anchor | |
| AU6656098A (en) | Treatment of infertility with leptin receptor ligands | |
| AU1555700A (en) | Clutch | |
| AU6351199A (en) | Pectins and the preparation thereof | |
| AU5882298A (en) | New analgesic composition | |
| AU2333099A (en) | Aryloxyanilides and related compounds | |
| AU9321198A (en) | Dosage forms having improved release properties | |
| HUP9902855A3 (en) | Preparation of sterol- and stanol-esters |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |